Five tips for making a medical device equivalence claim under the MDR

Sandra Gopinath
How to make a medical device equivalence claim under the MDR

Making a claim of medical device equivalence was a popular route to compliance under the MDD, saving companies time and money by avoiding the need to generate new clinical evidence. However, the advent of the EU MDR has changed the rules, meaning that equivalence is a more complicated option than it used to be.

In this article, we give you five tips for making an equivalence claim when performing Clinical Evaluation under the MDR.

Tip 1 - Understand the process

This may sound obvious, but the first thing to do is to ensure you know exactly what equivalence is.

Video: An in-depth look into medical device equivalence and its role in device approval under the MDR

Equivalence is the process of demonstrating that two or more devices are similar to the point that there is no clinically relevant difference in their safety and clinical performance. In other words, it’s much more than just showing they are ‘similar’ — equivalent means ‘effectively the same as’, meaning that it’s harder to prove than a claim of similarity.

As we’ll discuss shortly, an equivalence claim can only work if the subject device is shown to be clinically, technically, and biologically equivalent to another device in the market which is already CE marked. It won’t work if claiming equivalence to a device that is not CE-marked under the MDR - and yes, that includes devices in the UK too.

Tip 2 - Do the prep work

A claim of equivalence encompasses three aspects — the technical, biological, and clinical attributes of the device. So, if you are comparing two devices that have the same features but are built of different materials, it will not make the cut. Therefore, spend some time digging into the features of the subject and equivalent device in all three domains before making a claim.

According to MedDev 2.7/1 rev 4, equivalence claims should be backed up with strong scientific evidence. This may require an extensive literature search to address the device’s technical, biological, and clinical specifications.

The medical device manufacturer should identify and declare any differences between the two devices that are revealed during the literature appraisal – don’t shy away from them. Conducting a Gap Analysis to see whether there is a clinically relevant difference between your product and the proposed equivalent will also help you to flesh out the equivalence claim.

Along with this, the manufacturer may need information relating to the equivalent device that isn’t easy to obtain – which means another tip is to…

Tip 3 - Get sufficient access

Under the terms of the MDR, it’s necessary to show that you have sufficient access to data relating to the equivalent device.

100% compliant CERs

We have a 100% acceptance rate for CERs submitted for the EU & UK MDR.

Explore our Clinical Evaluation services

For class III devices, this requirement extends all the way to having a contract in place with the manufacturer of the equivalent device granting full access to technical files. Given that the equivalent device will often be made by a competitor, this all but rules out equivalence for many Class III devices.

While ‘sufficient access’ isn’t defined in detail for other classes of device, there are several principles to hold in mind. It’s worth phrasing the sufficient access statement around areas of uncertainty – so, for example, if it’s easily demonstrable from publicly-available information that two devices are technically equivalent, state that the ‘key data’ that must be accessed relates to biological and clinical characteristics. This helps narrow the scrutiny of the reviewer.

Furthermore, this may enable the performance of tests or direct experience with the device to meet the sufficiency test. Ultimately, meeting the access test comes down to a judgement call but it doesn’t always mean raiding a competitor’s technical files. With the exception of Class III devices, it’s about forming a reasoned argument and amassing as much information as you can.

Tip 4: - Go three dimensional

The three dimensions to be taken into consideration while demonstrating equivalence are technical, biological, and clinical characteristics of the devices. Having done the prep work, it’s time to form the argument. Here’s the low down on each aspect of equivalence:

Technical

Technical equivalency means that the device is of similar design; it is used under similar conditions; it has similar specifications and properties, including physicochemical properties; it employs similar deployment methods, where applicable; and it has similar operating principles and critical performance requirements.

Biological

The device employs the same materials or substances in touch with the same human tissues or body fluids for similar types and durations of contact, as well as similar substance release characteristics, such as degradation products and leachables.

Clinical

Clinical equivalency can be claimed only if the device is used for the same clinical condition including similar severity and stage of disease, at the same site in the body, in a similar population, including age, anatomy, and physiology; device has the same type of user; and has comparable relevant critical performance considering the expected clinical effect for a specific intended purpose.

Tip 5 - Get the message across

Having done all this work, don’t let your claim fail because it isn’t set out in a way that appeals to the reviewer. The most effective way to display the analysis and comparison of data is to prepare a set of tables comparing the devices’ technical, biological, and clinical properties, along with a column on the effects on any differences on clinical safety and performance. This forensic, line-by-line approach enables the reviewer to follow the argument as it builds. Any identified differences and their implications for safety and performance should be carefully justified in a paragraph following the tables.

Summary

Claiming equivalence under the MDR isn’t necessarily easy but it can save a pretty penny in clinical evidence costs. If you need more advice on working with equivalence, feel free to reach out to our team who are always available to help.

Mantra Systems has experience in producing equivalence claims under the MDR as part of our Clinical Evaluation service. If you would like to speak to us about how we could help you in this area, please contact a member of our team for a no-obligation discussion.

Related articles

  1. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  2. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  3. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  4. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Senior Regulatory Specialist
  5. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  6. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Lead Medical Writer
  7. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  8. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Lead Medical Writer
  9. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Senior Regulatory Specialist
  10. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  11. An update on UKCA Marking of Medical Devices

    UKCA Marking of Medical Devices – An update on the status quo

    We review recently updated requirements for UKCA marking and what it means for your regulatory strategy.

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  12. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  13. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Senior Regulatory Specialist
  14. Literature Search, SOTA Review and Clinical Evaluation

    Literature Search, SOTA Review process and Clinical Evaluation

    We help to demystify the process of systematic search & review of literature for Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Senior Regulatory Specialist
  15. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Senior Regulatory Specialist
  16. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  17. Avoid pitfalls when writing a Clinical Evaluation Report

    Five common pitfalls when writing a Clinical Evaluation Report

    We illustrate five pitfalls when writing CERs and give you some tips to overcome them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  18. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  19. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  20. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  21. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  22. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  23. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  24. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  25. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  26. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  27. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  28. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  29. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need help with your regulatory strategy?

Talk to us